MedTrace Logo

Phenytoin in the Healing of Clean Surgical Wounds

NCT02413658 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2015-04-10

No results posted yet for this study

Summary

The purpose of this study is to investigate the potential healing properties of phenytoin.

The investigators will use the donor site of a split skin thickness graft (SSTG) to model a basic wound in a randomized controlled trial of topical phenytoin against current best clinical practice. The investigators aim to demonstrate a dose dependent effect. The investigators hypothesis, based on previous clinical experience at our center and on current available literature, that phenytoin will reduce wound healing time.

Conditions

  • Wound
  • Re-Epithelialization

Interventions

DRUG

Phenytoin

Topical use of phenytoin solution on dressings of split thickness skin graft sites.

DRUG

Sugar solution

Sponsors & Collaborators

  • Children's Surgical Center, Cambodia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2016-04-30

Countries

  • Cambodia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02413658 on ClinicalTrials.gov